NetScientific Receives CE Mark for Immunoassay

NetScientific gained the CE Mark for its ProteaseTag active Pproteinase-3 immunoassay and announced its firm commercial sale to a US biotech company.

The company’s Plasmin and Neutrophil Elastase immunoassays have also received the CE Mark, and development is underway for further immunoassays.

The Pproteinase-3 immunoassay is designed for clinical researchers investigating chronic respiratory conditions, such as cystic fibrosis, bronchiectasis and chronic obstructive pulmonary disease, in both commercial and academic areas.